Drug Trial Radar · NCT04901936
A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Last checked: Nov 20, 2026Latest source record: Jun 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
12
Planned (sponsor's estimate)
Start
Feb 4, 2021
Primary completion
Dec 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- Apellis Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 26, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, effectiveness, and biological activity (how the investigational medication is processed by the body) of pegcetacoplan in 12-17 year-olds (adolescents) who have paroxysmal nocturnal hemoglobinuria (PNH).
Conditions
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Paroxysmal Hemoglobinuria
Interventions
PegcetacoplanDrug
Complement (C3) inhibitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pegcetacoplan serum concentrations over the course of the 16-week treatment periodTime frame: 16 weeks
- Change from baseline to Wk 16 in hemoglobin (Hb)Time frame: 16 weeks
- Incidence and severity of treatment-emergent adverse events (TEAEs) over the course of the 16-week treatment period, including monitoring bacterial infectionsTime frame: 16 weeks
- Change from baseline to wk 16 lactate dehydrogenase (LDH)Time frame: 16 weeks
- Change from baseline to wk 16 absolute reticulocyte count (ARC)Time frame: 16 weeks
Locations
12 sites in 9 countries. Site status is shown where the registry gives one.
Children's Hospital of Atlanta
Atlanta, Georgia · Recruiting
Motol University Hospital
Prague, Czechia · Completed
Robert-Debré Hospital Paris
Paris, France · Not yet recruiting
Hospital Ampang
Ampang, Malaysia · Recruiting
Radboud University Hospital Nijmegen
Nijmegen, Netherlands · Completed
University Medical Center Utrecht
Utrecht, Netherlands · Recruiting
University Children's Hospital
Belgrade, Serbia · Recruiting
University Hospital Vall d'Hebron
Barcelona, Spain · Recruiting
University Hospital 12 de Octubre
Madrid, Spain · Recruiting
Phramongkutklao Hospital and College of Medicine
Bangkok, Thailand · Completed
Maharaj Nakorn Chiang Mai hospital
Chiang Mai, Thailand · Recruiting
St. Mary's Hospital
London, United Kingdom · Completed
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.